AnGes, Inc.

TSE:4563.T

49 (JPY) • At close November 1, 2024
Bedrijfsnaam AnGes, Inc.
Symbool 4563.T
Munteenheid JPY
Prijs 49
Beurswaarde 12,586,602,805
Dividendpercentage 0%
52-weken bereik 43 - 98
Industrie Biotechnology
Sector Healthcare
CEO Dr. Ei Yamada M.D., Ph.D.
Website https://www.anges.co.jp

An error occurred while fetching data.

Over AnGes, Inc.

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy

Vergelijkbare Aandelen

SanBio Company Limited logo

SanBio Company Limited

4592.T

1,013 JPY

GNI Group Ltd. logo

GNI Group Ltd.

2160.T

3,025 JPY

CellSource Co., Ltd. logo

CellSource Co., Ltd.

4880.T

1,188 JPY

Eiken Chemical Co., Ltd. logo

Eiken Chemical Co., Ltd.

4549.T

2,322 JPY

Elan Corporation logo

Elan Corporation

6099.T

862 JPY

Pharma Foods International Co., Ltd. logo

Pharma Foods International Co., Ltd.

2929.T

957 JPY

CYBERDYNE Inc. logo

CYBERDYNE Inc.

7779.T

187 JPY

Solasto Corporation logo

Solasto Corporation

6197.T

479 JPY

Genky DrugStores Co., Ltd. logo

Genky DrugStores Co., Ltd.

9267.T

3,035 JPY

Shin Nippon Biomedical Laboratories, Ltd. logo

Shin Nippon Biomedical Laboratories, Ltd.

2395.T

1,221 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)